For Brazilian Companies

The Brazil to North America corridor prepares Brazilian biologicals evidence for regulatory, investor and partner review in Canada and the United States.

The science is strong. What most companies need is a credible bridge into North American capital, regulators, and partners, on terms that respect the work already done.

The Brazil–North America Gateway is that bridge.

Fale conosco em português

Why This Matters

The evidence has to be in the format the market asks for.

The science is rarely the problem.

Brazilian R&D culture, field trial depth, and regulatory experience run deep. What slows companies down is translating that work into the formats Canadian and U.S. investors, strategics, and regulators expect: claim language, IP framing, regulatory pathway, and trial protocols.

Trust closes deals.

North American partners ask for independent validation before committing. The Gateway supplies that assessment in the format they ask for.

How We Help

Three layers, designed to be used in sequence.

Readiness Review

Structured assessment across science, regulatory, IP, and go-to-market. Outputs a written readiness brief, a tier recommendation, and the specific gaps to close before approaching North American capital or partners.

Technical Translation

Brazilian evidence is translated into the formats North American regulators, investors, and partners require: claim language, regulatory pathway, IP framing, and trial protocol. Claim audit, regulatory pathway framing (PMRA, EPA, CFIA), IP landscape across CIPO, USPTO, EPO, INPI, WIPO, and competitive benchmarking.

Partner Introductions

Introductions to investors, strategics, and distributors in Canada and the United States, each supported by a QBIView evidence package.

Deliverables

An evidence package.

→QBIView Readiness Brief, scoped to stage
→Claim and regulatory translation for Canadian and U.S. requirements
→Independent IP landscape across CIPO, USPTO, INPI, the EPO, and PCT filings via WIPO
→Target-partner shortlist with warm introductions
→Ongoing relationship management across both markets

Pricing is tailored to the scope and complexity of each engagement and discussed during an initial consultation.

Confidential by default. Not sold. Not published. Not shared without permission.

Start the Conversation

Apply to the Gateway

Tell us about your company and your North American ambition. We respond within two business days.

Fale conosco em português Explore QBIView